Ildefonso Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ildefonso Silva has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Adrian L. Harris
Department of Oncology, University of Oxford, Oxford, UK
25 shared publications Alison Banham
25 shared publications- Cameron Snell
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
25 shared publications David M. Favara
25 shared publicationsDian Wang
25 shared publicationsEsther Bridges
25 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Springer Nature in Communications Biology
Immune checkpoint blockade activates macrophages and remodels the lymph node microenvironment in melanoma metastasis
- 9 October 2026
- Published by Springer Nature in Communications Biology
Open AccessImmune checkpoint blockade activates macrophages and remodels the lymph node microenvironment in melanoma metastasis
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig. S4. Effects of CD4+ T-cell intrinsic P2RX7 on tumor growth and Treg accumulation in the lungs.
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig. S4. Effects of CD4+ T-cell intrinsic P2RX7 on tumor growth and Treg accumulation in the lungs.
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig. S3. Effects of T-cell intrinsic P2RX7 on the growth of tumors in the lung.
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig. S3. Effects of T-cell intrinsic P2RX7 on the growth of tumors in the lung.
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig. S5. Effects of P2RX7 expression on Tregs in lung cancer experimental model.
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig. S5. Effects of P2RX7 expression on Tregs in lung cancer experimental model.
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Data from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Lung cancer is the leading cause of cancer-related deaths worldwide, and despite advances in treatment, immune suppression remains an obstacle to effective therapy. Effector CD4+ T cells (CD4+ Teff) are critical for antitumor immunity, but their function is often inhibited by regulatory T cells (Treg), which accumulate in lung tumors and mediate suppressive functions through multiple mechanisms. This suppression leads to tumor progression and poor patient outcomes. However, the mechanisms underlying Treg-mediated suppression are not fully understood. Herein, we identify the extracellular adenosine 5-triphosphate receptor P2RX7 as a key regulator of Treg function in lung tumors. In a murine lung cancer model induced by Lewis lung carcinoma cells, we found that P2RX7 enhanced the suppressive capacity of tumor-infiltrating Tregs, promoting tumor growth. In T cell–specific P2RX7-knockout (P2RX7-KO) mice, reduced Treg infiltration was accompanied by increased CD4+ Teff accumulation and improved tumor control. Treg-specific P2RX7-KO mice exhibited reduced tumor growth, confirming a Treg-intrinsic role of P2RX7. Suppression assays revealed that tumor-infiltrating wild-type Tregs had greater suppressive activity compared with P2RX7-KO Tregs, which failed to inhibit type 1 and follicular helper T–like responses. This was associated with increased tumor-specific IgG production by lung B cells in P2RX7-KO mice. We also observed that wild-type Tregs expressed higher levels of the immunosuppressive molecule CTLA-4 when compared with P2RX7-KO Tregs. Thus, we conclude that P2RX7 expression on Tregs is essential for their suppressive function in lung cancer and targeting P2RX7 may constitute a strategy to improve lung cancer treatment by alleviating Treg-mediated immune suppression.
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Lung cancer is the leading cause of cancer-related deaths worldwide, and despite advances in treatment, immune suppression remains an obstacle to effective therapy. Effector CD4+ T cells (CD4+ Teff) are critical for antitumor immunity, but their function is often inhibited by regulatory T cells (Treg), which accumulate in lung tumors and mediate suppressive functions through multiple mechanisms. This suppression leads to tumor progression and poor patient outcomes. However, the mechanisms underlying Treg-mediated suppression are not fully understood. Herein, we identify the extracellular adenosine 5-triphosphate receptor P2RX7 as a key regulator of Treg function in lung tumors. In a murine lung cancer model induced by Lewis lung carcinoma cells, we found that P2RX7 enhanced the suppressive capacity of tumor-infiltrating Tregs, promoting tumor growth. In T cell–specific P2RX7-knockout (P2RX7-KO) mice, reduced Treg infiltration was accompanied by increased CD4+ Teff accumulation and improved tumor control. Treg-specific P2RX7-KO mice exhibited reduced tumor growth, confirming a Treg-intrinsic role of P2RX7. Suppression assays revealed that tumor-infiltrating wild-type Tregs had greater suppressive activity compared with P2RX7-KO Tregs, which failed to inhibit type 1 and follicular helper T–like responses. This was associated with increased tumor-specific IgG production by lung B cells in P2RX7-KO mice. We also observed that wild-type Tregs expressed higher levels of the immunosuppressive molecule CTLA-4 when compared with P2RX7-KO Tregs. Thus, we conclude that P2RX7 expression on Tregs is essential for their suppressive function in lung cancer and targeting P2RX7 may constitute a strategy to improve lung cancer treatment by alleviating Treg-mediated immune suppression.
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig. S6. Effects of Treg-specific P2RX7 ablation on Teffs in experimental lung cancer model.
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig. S6. Effects of Treg-specific P2RX7 ablation on Teffs in experimental lung cancer model.
- Open Access
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig.S1. Gate strategy for flow cytometry analysis.
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Regulatory T-cell Sensing of Extracellular ATP via P2RX7 Promotes Their Accumulation and Suppression and Drives Lung Tumor Growth
Fig.S1. Gate strategy for flow cytometry analysis.